Dennis E. Hruby Sells 50,000 Shares of SIGA Technologies, Inc. (OTCMKTS:SIGA) Stock

SIGA Technologies, Inc. (OTCMKTS:SIGA) VP Dennis E. Hruby sold 50,000 shares of SIGA Technologies stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $5.61, for a total value of $280,500.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

SIGA opened at $5.68 on Friday. The firm has a 50-day moving average price of $5.57. SIGA Technologies, Inc. has a 1 year low of $4.68 and a 1 year high of $8.47.

SIGA Technologies (OTCMKTS:SIGA) last released its quarterly earnings results on Thursday, May 2nd. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $10.46 million during the quarter.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. O Shaughnessy Asset Management LLC acquired a new stake in shares of SIGA Technologies in the first quarter valued at about $72,000. BNP Paribas Arbitrage SA acquired a new stake in shares of SIGA Technologies in the first quarter valued at about $79,000. BB&T Securities LLC acquired a new stake in shares of SIGA Technologies in the fourth quarter valued at about $81,000. Algert Global LLC acquired a new stake in shares of SIGA Technologies in the fourth quarter valued at about $85,000. Finally, TRUE Private Wealth Advisors acquired a new stake in shares of SIGA Technologies in the first quarter valued at about $85,000. 6.66% of the stock is currently owned by hedge funds and other institutional investors.

Separately, TheStreet downgraded SIGA Technologies from a “b” rating to a “c+” rating in a research note on Friday, May 10th.

SIGA Technologies Company Profile

SIGA Technologies, Inc is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company’s lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield).

See Also: Treasury Bonds

Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.